France’s Aqemia bags €30M from Eurazeo, Bpifrance, others to scale drug discovery using AI

Funding Rounds

▤ Summary

France-based Aqemia, a deep physics and AI enabled drug discovery pipeline company, announced on Wednesday, October 19, that it has raised €30 million in a Series A round of funding led by Eurazeo and Bpifrance’s Large Venture Fund. Existing investor Elaia also participated in the round. Aqemia says that the funding will support its core mission to massively scale drug discovery through a first-in-class technological platform combining quantum-inspired physics and machine learning.

$ Funding

$
Amount - Total raised
□
Date - Announcement date
◎
Investors Eurazeo Lead investors
▥
Company - Funded company

▥ Classifications

industries
Fintech & Banking
applications
Accounting and Taxes

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies